Cis-activation in the Notch signaling pathway

Abstract

The Notch signaling pathway consists of transmembrane ligands and receptors that can interact both within the same cell (cis) and across cell boundaries (trans). Previous work has shown that cis-interactions act to inhibit productive signaling. Here, by analyzing Notch activation in single cells while controlling cell density and ligand expression level, we show that cis-ligands can also activate Notch receptors. This cis-activation process resembles trans-activation in its ligand level dependence, susceptibility to cis-inhibition, and sensitivity to Fringe modification. Cis-activation occurred for multiple ligand-receptor pairs, in diverse cell types, and affected survival in neural stem cells. Finally, mathematical modeling shows how cis-activation could potentially expand the capabilities of Notch signaling, for example enabling ‘negative’ (repressive) signaling. These results establish cis-activation as an additional mode of signaling in the Notch pathway, and should contribute to a more complete understanding of how Notch signaling functions in developmental, physiological, and biomedical contexts.

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 10, 2019
Source ID
10.7554/elife.37880

Entities

People

  • Leah A Santat
  • Michael Elowitz
  • Nagarajan Nandagopal

Organizations

  • California Institute of Technology
  • Howard Hughes Medical Institute
  • National Institutes of Health
  • National Science Foundation

Tags

Fields of Study

  • Biology

Readers

  • Breast cancer cell signaling and growth regulation.
  • Molecular Biology and Genetics
  • Theoretical Analysis.

Technology Areas

  • Biotechnology
  • Biotechnology - Bioremediation